C4 Therapeutics, Inc. · NASDAQ:CCCC
C4 Therapeutics, Inc. shareholders
As of Sep 30, 2026, 146 institutions reported holding C4 Therapeutics, Inc. Largest: Squadron Capital Management LLC, Morgan Stanley and Ra Capital Management, L.P. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of C4 Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Squadron Capital Management LLC | 9.32M | +2.12M | Nov 16, 2026 | |
| Morgan Stanley | 8.87M | +5,296 | Nov 13, 2026 | |
| Ra Capital Management, L.P. | 8.19M | +195K | Nov 16, 2026 | |
| BlackRock | 8.18M | +283K | Nov 13, 2026 | |
| Lynx1 Capital Management LP | 7.53M | +204K | Nov 16, 2026 | |
| Bain Capital Life Sciences Investors, LLC | 7.17M | no change | Nov 16, 2026 | |
| Vanguard | 6.46M | +700K | Nov 16, 2026 | |
| Citadel | 5.01M | +819K | Nov 16, 2026 | |
| JPMorgan | 4.7M | −50,440 | Nov 12, 2026 | |
| Goldman Sachs | 4.68M | +1.15M | Nov 16, 2026 |